Exhibit 99.2

OPERATING AND FINANCIAL REVIEW AND PROSPECTS

You should read the following selected financial data and discussion of our operating and financial condition and prospects in conjunction with the financial statements and the notes thereto included elsewhere in this 6-K. Our financial statements are prepared in in accordance with generally accepted accounting principles of the United States of America, or U.S. GAAP.

This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under “Item 3.D. Risk Factors” and elsewhere in the Company’s annual report in Form 20-F.

Unless otherwise indicated, all references to the “Company,” “we,” “our” and “Nano Dimension” refer to Nano Dimension Ltd. and its subsidiaries, Global Inkjet Systems Ltd., or GIS, a United Kingdom corporation, Nano Dimension Technologies Ltd., or Nano Tech, an Israeli corporation, Essemtec AG, or Essemtec and Nano Dimension Swiss GmbH, or Nano Swiss, Swiss corporations,,, Nano Dimension USA Inc., or Nano USA, a Delaware corporation, Essemtec USA, LLC, a Delaware limited liability company, Nano Dimension GmbH, or Nano Germany and Essemtec Deutschland GmbH, German corporations, Nano Dimension Australia Pty Ltd., or Nano Australia, an Australian corporation, Nano Dimension (HK) Limited, a Hong Kong corporation, Essemtec France SAS, a French corporation, Nano Dimension NY Ltd., a New York corporation, Nano Dimension Trading (Shenzhen) Ltd., a Chinese corporation,, Desktop Metal Inc, or Desktop, a Delaware corporation (which is in bankruptcy proceedings), the subsidiaries of Desktop as listed in Exhibit 21.1 to the 10-K report filed by Desktop on March 15, 2024, Markforged Holding Corporation, or Markforged, a Delaware corporation, and the subsidiaries of Markforged as listed in Exhibit 21.1 to the 10-K report filed by Markforged on March 28, 2025.

References to “U.S. dollars” and “$” are to currency of the United States of America, and references to “NIS” are to New Israeli Shekel. References to “Ordinary Shares” are to our Ordinary Shares, par value of NIS 5.00 per share.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information included in the financial statements and the notes thereto included elsewhere in this 6-K. may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.

These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.

Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things:

the integration of the operations of Markforged into our business;
the outcome of the independent process now being conducted by Desktop Metal to evaluate all available strategic alternatives to address its liabilities and liquidity needs;
the transformation of our business resulting from the change in our management;
changes in our strategy;
the impact of competition and new technologies;
shareholder activism;
the overall global economic environment;

projected capital expenditures and liquidity;
litigation; and
those factors referred to in “Item 3. Key Information – D. Risk Factors,” “Item 4. Information on the Company,” and “Item 5. Operating and Financial Review and Prospects”, of our annual report on Form 20-F.

Readers are urged to carefully review and consider the various disclosures made throughout this 6-K which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

You should not put undue reliance on any forward-looking statements. Any forward-looking statements in this 6-K are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Overview

We innovate and provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

We do this through innovating and providing industrial manufacturing solutions that are built around multi-disciplinary technology - combining hardware, software, and materials science.

As part of the re-assessment program initiated by our new management in January 2025, our business and operations are currently being refocused based on the following principles, which we believe will enable us to differentiate our business from our competitors:

Prioritizing manufacturing of industrial parts, rather than fabricating R&D concept,
Building technology that scales with the needs of manufacturing, and
Preserving capital for strategic moves and avoid short-term survival mindset.

As a result, we are focusing on products and services where there is innovative technology with a growth outlook that can deliver sustainable improvements in our financial results and to discontinue certain product groups that have failed to generate adequate returns on investment and that do not align with our long-term objectives.

Including Markforged, the Company has the following product groups:

Aidro – Advanced hydraulic systems
Adaptive3D – Resins
DentalLabs –Dental parts services
DragonFly - Additively manufactured electronics (AME)
EnvisionTech – Additive manufacturing digital light processing (DLP)-based systems for industrial and health applications
Essemtec – Surface-mount technology
ExOne – Binder jetting for metal and sandcasting
Global Inkjet Systems (GIS) – Digital printing sub-components hardware and software
Markforged – Desktop and industrial fused filament fabrication (FFF) solutions
PX100 – Binder jetting for metal

These solutions are sold to industrial leaders and organizations, including: aerospace, defense, automotive, electronics, medical, research and academia, as well as government organizations

Our management has already resolved to discontinue the operations of certain of our product groups, as follows:

Admatec - Additive manufacturing DLP-based systems for ceramic and metal applications
DeepCube - Industrial AI
Fabrica - Additive manufacturing DLP-based systems for micro applications
Formatec - Manufacturing services for metal and ceramic applications
J.A.M.E.S. – AME online community platform

Adamtec, Formatec, and Formatec Holdings were declared bankrupt in April 2025. Additionally, in April 2025, the Advisory Board of J.A.M.E.S resolved to discontinue its operations.

We believe that additive manufacturing (AM), which is known to some as 3D printing, of electronics and precision applications are key to future growth in the manufacturing industry.

We have offices spanning across the United States, Germany, Israel, Japan, UK, Sweden, and Switzerland. These offices serve to broaden our customer engagement across regions and serve as focal points for advancing our strategic objectives. To date, some of our offices are those of a single product group, while others include teams representing more than one product group. Integrating these teams and offices is important to our ability to realize synergies in sales and marketing.

To date, we have generated revenues from the sale of our products and related services. In the fourth quarter of 2017 we began commercializing our products and our ability to generate significant revenues and achieve profitability depends on our ability to successfully complete the development of, and to continue to commercialize, our products, including consumables. As of December 31, 2024, we had an accumulated deficit of $677,665,00. Our financing activities are described below under “Liquidity and Capital Resources.”

A. Operating Results

Operating Expenses

Our current operating expenses consist of three main components – research and development expenses, sales and marketing expenses and general and administrative expenses.

Research and Development Expenses

Our research and development expenses consist of payroll and related expenses, share-based payments expenses, rental fees and maintenance, subcontractors expenses, materials for R&D use, depreciation, and other related research and development expenses.

The following table discloses the breakdown of research and development expenses:

    

Year ended December 31,

(in thousands of U.S dollars)

    

2023

    

2024

Payroll

33,462

23,276

Share-based payment expenses

10,297

6,079

Subcontractors

6,717

2,211

Materials for R&D use

6,584

1,853

Rental fees and maintenance

3,782

2,671

Depreciation

1,427

1,355

Other expenses

2,877

2,113

Total

65,146

39,558

Sales and Marketing Expenses

Sales and marketing expenses consist of payroll and related expenses, marketing and advertising services, travel expenses, share-based payments expenses, rental fees and maintenance, depreciation, as well as other related sales and marketing expenses.


The following table discloses the breakdown of sales and marketing expenses:

    

Year ended December 31,

(in thousands of U.S dollars)

    

2023

    

2024

Payroll

19,075

15,584

Share-based payment expenses

4,891

1,649

Marketing and advertising

4,685

5,096

Depreciation

16

518

Travel abroad

2,555

1,808

Rental fees and maintenance

1,822

1,642

Other expenses

1,214

1,360

Total

34,258

27,657

General and Administrative Expenses

General and administrative expenses consist of payroll and related expenses, professional services, share-based payments expenses, rental fees and maintenance, travel expenses,office expenses, depreciation, as well as other general and administrative expenses.

The following table discloses the breakdown of general and administrative expenses:

    

Year ended December 31,

(in thousands of U.S dollars)

    

2023

    

2024

Payroll

14,032

13,542

Share-based payment expenses

6,111

7,055

Professional services

29,122

11,109

Office expenses

1,613

1,293

Depreciation

413

395

Travel abroad

674

1,368

Rental fees and maintenance

1,084

1,721

Other expenses

2,924

3,052

Total

55,973

39,535

Comparison of the year ended December 31, 2024 to the year ended December 31, 2023

Results of Operations

    

Year ended December 31,

(in thousands of U.S dollars)

    

2023

    

2024

Consolidated Statements of Operations Data

Revenues

56,314

57,775

Cost of revenues

30,159

31,231

Cost of revenues - write-down of inventories and amortization of technology

97

1,655

Gross profit

26,058

24,889

Research and development expenses

65,146

39,558

Sales and marketing expenses

34,258

27,657

General and administrative expenses

55,973

39,535

Other expenses (income), net

(1,627)

5,966

Impairment loss

1,283

Operating loss

(127,692)

(89,110)

Finance income

47,584

42,573

Finance expenses

(367)

(668)

Gain (loss) on investment in marketable equity securities

23,462

(52,256)

Loss before taxes

(57,013)

(99,461)

Taxes expenses

(62)

(397)

Loss for the year

(57,075)

(99,858)

Loss attributable to non-controlling interests

(1,110)

(1,029)

Loss attributable to owners

(55,965)

(98,829)


Revenues

Our revenues for the year ended December 31, 2024 amounted to $57,775,000, representing an increase of $1,461,000 or 3%, compared to $56,314,000 for the year ended December 31, 2023. The increase is attributed mostly to increased and more effective sales efforts.

Total Cost of Revenues

Our total cost of revenues for the year ended December 31, 2024 amounted to $32,886,000, representing an increase of $2,630,000 or 9%, compared to $30,256,000, for the year ended December 31, 2023. Total cost of revenues consists mainly of raw materials, materials and consumables in the amount of $20,315,000, payroll and related expenses in the amount of $9,118,000, other related costs (mainly depreciation and rental maintenance expenses) in the amount of $1,798,000 and write-down of inventories and amortization of technology in the amount of $1,655,000. The increase resulted primarily from the above-mentioned increase in revenues and an increase in the cost of revenues related to write-down of inventories following the discontinuation of Fabrica product lines.

Gross Profit

Our gross profit for the year ended December 31, 2024 amounted to $24,889,000, compared to a gross profit of $26,058,000 for the year ended December 31, 2023. The decrease resulted primarily from the increase in the write-down of inventories related to discontinued Fabrica product lines.

Research and Development Expenses

Our research and development expenses for the year ended December 31, 2024 amounted to $39,558,000, representing a decrease of $25,588,000, or 39%, compared to $65,146,000 for the year ended December 31, 2023. The decrease is mainly attributed to a decrease of $10,186,000 in payroll and related expenses, a decrease of $9,237,000 in materials for R&D use and subcontractors expenses, as well as a decrease of $4,218,000 in share-based payments expenses.

Sales and marketing Expenses

Our sales and marketing expenses for the year ended December 31, 2024 amounted to $27,657,000, a decrease of $6,601,000 or 19%, compared to $34,258,000 for the year ended December 31, 2023. The decrease is mainly attributed to a decrease of $3,491,000 in payroll and related expenses and a decrease of $3,242,000 in share-based payments expenses.

General and Administrative Expenses

Our general and administrative expenses amounted to $39,535,000 for the year ended December 31, 2024, a decrease of $16,438,000 or 29%, compared to $55,973,000 for the year ended December 31, 2023. The decrease is mainly attributed to a decrease of $18,013,000 in professional services, mainly from proxy contest and legal related expenses.

Other Expenses, Net

Our other expenses, net for the year ended December 31, 2024 amounted to $5,966,000 compared to other income, net of $1,627,000 for the year ended December 31, 2023. In 2024 the amount is mainly attributed to Desktop Metal and Markforged transaction related expenses. In 2023 the amount represents compensation from government authorities for damaged inventory, partially offset by reorganization costs incurred during the year.

Operating Loss

As a result of the foregoing, our operating loss for the year ended December 31, 2024 was $89,110,000 as compared to an operating loss of $127,692,000 for the year ended December 31, 2023, a decrease of $38,582,000 or 30%, mainly as a result of the reorganization plan executed by the Company in the fourth quarter of 2023 and other cost reduction efforts taken in 2024.

Finance Expenses and Income

Finance expenses and income mainly consist of bank interest, exchange rate differencesand bank fees.

We recognized net financial income of $41,905,000 for the year ended December 31, 2024, compared to net financial income of $47,217,000 for the year ended December 31, 2023, a decrease of $5,312,000 or 11%. The decrease is primarily attributed to a decrease of $3,331,000 in bank interest. In addition, in the year ended December 31, 2024, we had $485,000 foreign currency losses, compared to $1,722,000 foreign currency gains for the year ended December 31, 2023.


Total Loss

As a result of the foregoing, our total loss for the year ended December 31, 2024 was $99,858,000, compared to $57,075,000 for the year ended December 31, 2023, an increase of $42,783,000, or 75%. The increase is mainly attributed to the revaluation of our investment in Stratasys’ shares.

B. Liquidity and Capital Resources

Overview

Since our inception through December 31, 2024, we have funded our operations principally with $1,550,642,000 from issuance of Ordinary Shares, warrants and convertible notes. As of December 31, 2024, and following (i) the execution of a $166 million Repurchase Plans during 2023-2024; and (ii) the acquisition of the Stratasys shares, we held $317,169,000 in cash and cash equivalents along with an additional $440,790,000 in short-term unrestricted bank deposits.

The table below presents our cash flows:

    

December 31,

(in thousands of U.S. dollars)

    

2023

    

2024

Operating activities

(68,661)

(18,908)

Investing activities

(198,874)

97,246

Financing activities

(109,548)

(69,743)

Net increase (decrease) in cash

(377,083)

8,595

Operating Activities

Net cash used in operating activities of $18,908,000 during the year ended December 31, 2024 was primarily used for payment of payroll and related expenses, payments for materials and inventory, professional services, rental fees and maintenance, travel and other miscellaneous expenses, offset by interest received from banks.

Net cash used in operating activities of $68,661,000 during the year ended December 31, 2023 was primarily used for payment of payroll and related expenses, payments for materials and inventory, rent, travel, professional services and other miscellaneous expenses, offset by interest received from banks.

Investing Activities

Net cash from investing activities of $97,246,000 during the year ended December 31, 2024 was primarily from change in our cash in bank deposits.

Net cash used in investing activities of $198,874,000 during the year ended December 31, 2023 was used for investments of our cash in bank deposits and fixed assets.

Financing Activities

Net cash used in financing activities of $69,743,000 in the year ended December 31, 2024 was mainly due to repurchase of our ADSs.

Net cash used in financing activities of $109,548,000 in the year ended December 31, 2023 mainly due to repurchase of our ADSs.

Share Repurchase

In February 2023, we announced that we would put into action our previously announced share repurchase plan, or the $100 million Repurchase Plan, allowing us to invest up to $100 million to repurchase our ADSs from time to time, in open market transactions, and/or in privately negotiated transactions or in other legally permissible ways, depending on market conditions, share price, trading volume and other factors. The $100 million Repurchase Plan was approved by the Israeli court in in August 2022 for a period of up to 12 months and was later extended by an additional two months. The $100 million Repurchase Plan expired on October 12, 2023, with $4,160,138 remaining, and thereafter no longer eligible for repurchases under such plan. All repurchases made in 2023 were made pursuant to the $100 million Repurchase Plan.

In August 2023, our board of directors authorized a repurchase plan, or the $200 million Repurchase Plan, allowing us to invest up to $200 million to repurchase ADSs from time to time, in open market transactions, and/or in privately negotiated transactions or in any other legally permissible ways, depending on market conditions, share price, trading volume and other factors. The Israeli court approved


the $200 million Repurchase Plan on October 17, 2023 for a twelve-month period. The $200 million Repurchase Plan expired on October 16, 2024, with $130,504,940 remaining, and thereafter no longer eligible for repurchases under such plan. All repurchases made in 2024 were made pursuant to the $200 million Repurchase Plan.

In January 2025, our board of directors authorized a repurchase plan, or the $150 million Repurchase Plan, allowing us to invest up to $150 million to repurchase ADSs from time to time, in open market transactions, and/or in privately negotiated transactions or in any other legally permissible ways, depending on market conditions, share price, trading volume and other factors. As of the date hereof, Repurchase Plan has yet to go into effect.

See “Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers” on our Form 20-F for the year ended December 31, 2024 for additional information.

Current Outlook

To date, we have not achieved profitability and have sustained net losses in every fiscal year since our inception, and we have financed our operations primarily through proceeds from issuance of our Ordinary Shares, warrants and convertible notes. Our primary requirements for liquidity and capital resources are to finance working capital, capital expenditures and general corporate purposes. Markforged, one of the companies that we recently acquired, and the results of which will be consolidated into our financials statements for 2025, also has a history of losses. Desktop Metal, a company we acquired in 2025 will also have its results for the period beginning with our acquisition of the company until Desktop Metal’s bankruptcy filing consolidated into our financial statements for 2025. Desktop metal also has a history of losses.

We believe we will continue to incur operating losses and negative cash flow in the near-term as we continue to invest in our business, in particular across our research and development efforts and sales and marketing programs. Nevertheless, we believe that our current resources will be sufficient to meet our business needs for at least the next 12 months.

In addition, our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds sooner than planned. Our future capital requirements will depend on many factors, including:

the success of our new strategy for growth;
our desire and ability to integrate the operations of Desktop and Markforged in our business, including any divestures of assets required;
potential obligations arising in connection with the acquisitions of Desktop and Markforged
the progress and costs of our research and development activities;
the progress of commercial sales of our products;
the costs of manufacturing our products;
the costs of filing, prosecuting, enforcing and defending patent claims, intellectual property rights and other legal claims;
the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally;
the magnitude of our general and administrative expenses. and
the current bankruptcy proceedings and resolution of other legal matters related to Desktop Metal.

Reconciliation of IFRS to U.S. GAAP

Our audited consolidated financial statements included in this Form 6-K are our first consolidated financial statements prepared in accordance with U.S. GAAP. The financial statements were presented in US GAAP from date of inception.

For all periods up to and including the fiscal year ending on December 31, 2024, the Company prepared its financial statements in accordance with United States generally accepted accounting principles. An explanation of the principal adjustments made in representing its IFRS financial statements, in order to comply with U.S. GAAP, is provided below.


The following tables present a reconciliation of the consolidated balance sheet as of December 31, 2024 and 2023 of IFRS compared to U.S. GAAP:

December 31,2024

    

IFRS

    

GAAP
Adjustments

    

U.S GAAP

    

Note

USD

Assets

Cash and cash equivalents

317,169

317,169

Bank deposits

440,790

440,790

Restricted deposits

537

537

Trade receivables

9,141

9,141

Other receivables

4,790

4,790

Inventory

16,899

16,899

Total current assets

789,326

789,326

Restricted deposits

768

768

Marketable equity securities

86,190

86,190

Property plant and equipment, net

14,143

14,143

Right-of-use assets

1

9,307

651

9,958

Intangible assets, net

2,155

2,155

Total non-current assets

112,563

651

113,214

Total assets

$

901,889

651

902,540

Note

Liabilities

Trade payables

4,249

4,249

Other payables

3

22,461

(167)

22,294

Current portion of lease liability

1

3,968

(547)

3,421

Current portion of bank loan

138

138

Total current liabilities

30,816

(714)

30,102

Liability in respect of government grants

3

843

(843)

Employee benefits

4,700

4,700

Lease liability

1

6,547

160

6,707

Deferred tax liabilities

Bank loan

276

276

Total non-current liabilities

12,366

(683)

11,683

Total liabilities

43,182

(1,397)

41,785

Equity

Non-controlling interests

715

715

Share capital

409,145

409,145

Additional paid-in capital

2,4

1,304,617

(7,269)

1,297,348

Treasury shares

(167,651)

(167,651)

Foreign currency translation reserve

1,044

1,044

Remeasurement of pension and postretirement benefit plans

(2,062)

(119)

(2,181)

Accumulated loss

(687,101)

9,436

(677,665)

Equity attributable to owners of the Company

857,992

2,048

860,040

Total equity

858,707

2,048

860,755

Total liabilities and equity

901,889

651

902,540


    

December 31,2023

    

IFRS

    

GAAP
Adjustments

    

U.S GAAP

    

Note

USD

Assets

Cash and cash equivalents

309,571

309,571

Bank deposits

541,967

541,967

Restricted deposits

60

60

Trade receivables

12,710

12,710

Other receivables

11,290

11,290

Inventory

18,390

18,390

Total current assets

893,988

893,988

Restricted deposits

881

881

Marketable equity securities

138,446

138,446

Property plant and equipment, net

16,716

16,716

Right-of-use assets

1

12,072

287

12,359

Intangible assets, net

2,235

2,235

Total non-current assets

170,350

287

170,637

Total assets

$

1,064,338

287

1,064,625

Note

Liabilities

Trade payables

4,696

4,696

Other payables

3,4

25,265

(318)

24,947

Current portion of lease liability

1

4,473

(1,131)

3,342

Current portion of bank loan

38

38

Total current liabilities

34,472

(1,449)

33,023

Liability in respect of government grants

23

1,895

(1,895)

Employee benefits

2,773

2,773

Lease liability

1

8,742

486

9,228

Deferred tax liabilities

75

75

Bank loan

595

595

Total non-current liabilities

14,080

(1,409)

12,671

Total liabilities

48,552

(2,858)

45,694

Equity

Non-controlling interests

1,011

1,011

Share capital

400,700

400,700

Additional paid-in capital

2,4

1,299,542

(9,107)

1,290,435

Treasury shares

(97,896)

(97,896)

Foreign currency translation reserve

2,929

2,929

Remeasurement of pension and postretirement benefit plans

707

(119)

588

Accumulated loss

(591,207)

12,371

(578,836)

Equity attributable to owners of the Company

1,014,775

3,145

1,017,920

Total equity

1,015,786

3,145

1,018,931

Total liabilities and equity

1,064,338

287

1,064,625


The following tables present a reconciliation of the consolidated statement of profit or loss for the years ended of December 31, 2024, 2023 and 2022 of IFRS compared to U.S. GAAP:

Year Ended December 31,2024

USD

Note

IFRS

GAAP Adjustments

U.S. GAAP

    

    

    

Leases

    

Share-
Based 
Compensation

    

Other

    

Revenues

57,775

57,775

Cost of revenues

1,2

31,125

33

73

31,231

Cost of revenues - write-down of inventories and amortization of assets recognized in business combination and technology

1,655

1,655

Total cost of revenues

32,780

33

73

32,886

Gross profit

24,995

(33)

(73)

24,889

Operating expenses

Research and development expenses

1,2,3

37,157

269

1,952

180

39,558

Sales and marketing expenses

1,2

26,951

199

507

27,657

General and administrative expenses

1,2

40,059

170

(694)

39,535

Other expenses (income), net

5,966

5,966

Impairment losses

1,283

1,283

Total Operating expenses

111,416

638

1,765

180

113,999

Operating loss

(86,421)

(671)

(1,838)

(180)

(89,110)

Finance income

3

43,540

(967)

42,573

Finance expenses

1,4

(1,389)

777

(56)

(668)

Gain (loss) on investment in marketable equity securities

(52,256)

(52,256)

Loss before taxes on income

(96,526)

106

(1,838)

(1,203)

(99,461)

Taxes expenses

(397)

(397)

Net loss

(96,923)

106

(1,838)

(1,203)

(99,858)

Loss attributable to non-controlling interests

(1,029)

(1,029)

Loss attributable to owners of the Company

(95,894)

106

(1,838)

(1,203)

(98,829)

Net Loss per share

Basic and diluted loss per share

(0.44)

-0.01

(0.45)

Weighted average shares outstanding, basic and diluted

218,311

218,311

Net loss

(96,923)

106

(1,838)

(1,203)

(99,858)

Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss

Foreign currency translation differences for foreign operations

(1,944)

(1,944)

Remeasurement of pension and postretirement benefit plan, net of tax

(2,769)

(2,769)

Total other comprehensive income (loss) for the year

(4,713)

(4,713)

Total comprehensive loss for the year

(101,636)

106

(1,838)

(1,203)

(104,571)

Comprehensive loss attributable to non-controlling interests

(1,088)

(1,088)

Comprehensive loss attributable to owners of the Company

(100,548)

106

(1,838)

(1,203)

(103,483)


Year Ended December 31,2023

USD

Note

IFRS

GAAP Adjustments

U.S. GAAP

    

    

    

Leases

    

Share-
Based 
Compensation

    

Other

    

Revenues

56,314

56,314

Cost of revenues

1,2

30,759

30

(630)

30,159

Cost of revenues - write-down of inventories and amortization of assets recognized in business combination and technology

97

97

Total cost of revenues

30,856

30

(630)

30,256

Gross profit

25,458

(30)

630

26,058

Operating expenses

Research and development expenses

1,2,3

62,004

269

2,575

298

65,146

Sales and marketing expenses

1,2

31,707

150

2,401

34,258

General and administrative expenses

1,2

58,254

57

(2,338)

55,973

Other expenses (income), net

(1,627)

(1,627)

Impairment losses

Total Operating expenses

150,338

476

2,638

298

153,750

Operating loss

(124,880)

(506)

(2,008)

(298)

(127,692)

Finance income

4

47,472

112

47,584

Finance expenses

1,3

(1,652)

816

469

(367)

Gain (loss) on investment in marketable equity securities

23,462

23,462

Loss before taxes on income

(55,598)

3181

(2,008)

283

(57,013)

Taxes expenses

(62)

(62)

Net loss

(55,660)

311

(2,008)

283

(57,075)

Loss attributable to non-controlling interests

(1,110)

(1,110)

Loss attributable to owners of the Company

(54,550)

310

(2,008)

283

(55,965)

Net Loss per share

Basic and diluted loss per share

(0.22)

(0.01)

(0.23)

Weighted average shares outstanding, basic and diluted

248,019

248,019

Net loss

(55,660)

310

(2,008)

283

(57,075)

Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss

Foreign currency translation differences for foreign operations

2,368

2,368

Remeasurement of pension and postretirement benefit plan, net of tax

(1,801)

(119)

(1,920)

Total other comprehensive income (loss) for the year

567

(119)

448

Total comprehensive loss for the year

(55,093)

310

(2,008)

164

(56,627)

Comprehensive loss attributable to non-controlling interests

(1,088)

(1,088)

Comprehensive loss attributable to owners of the Company

(54,005)

310

(2,008)

164

(55,539)


    

    

Year Ended December 31,2022

USD

Note

IFRS

    

GAAP Adjustments

U.S. GAAP

Share- Based

    

    

Leases

    

Compensation

Other

Revenues

43,633

43,633

Cost of revenues

1,2

24,943

38

(1,267)

23,714

Cost of revenues - write-down of inventories and amortization of assets recognized in business combination and technology

4,639

4,639

Total cost of revenues

29,582

38

(1,267)

28,353

Gross profit

14,051

(38)

1,267

15,280

Operating expenses

Research and development expenses

1,2,3

75,763

526

(4,716)

219

71,792

Sales and marketing expenses

1,2

38,833

258

(2,052)

37,039

General and administrative expenses

1,2

28,865

48

6,686

35,599

Other expenses (income), net

1,592

1,592

Impairment losses

40,523

40,523

Total Operating expenses

185,576

832

(82)

219

186,545

Operating loss

(171,525)

(870)

1,349

(219)

(171,265)

Finance income

1,4

22,965

826

(3,284)

20,507

Finance expenses

1,3

(16,680)

334

217

(16,129)

Gain (loss) on investment in marketable equity securities

(62,791)

(62,791)

Loss before taxes on income

(228,031)

290

1,349

(3,286)

(229,678)

Taxes expenses

(264)

(264)

Net loss

(228,295)

290

1,349

(3,286)

(229,942)

Loss attributable to non-controlling interests

(872)

(872)

Loss attributable to owners of the Company

(227,423)

290

1,349

(3,286)

(229,070)

Net Loss per share

Basic and diluted loss per share

(0.88)

(0.01)

(0.89)

Weighted average shares outstanding, basic and diluted

257,794

257,794

Net loss

(228,295)

290

1,349

(3,286)

(229,942)

Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss

Foreign currency translation differences for foreign operations

(844)

(844)

Remeasurement of pension and postretirement benefit plan, net of tax

2,508

2,508

Total other comprehensive income (loss) for the year

1,664

1,664

Total comprehensive loss for the year

(226,631)

290

1,349

(3,286)

(228,278)

Comprehensive loss attributable to non-controlling interests

(892)

(892)

Comprehensive loss attributable to owners of the Company

(225,739)

290

1,349

(3,286)

(227,386)


Notes to the main adjustments made in order to comply with U.S. GAAP:

1.Operating lease right of use assets:

Under IFRS, we recognized depreciation expenses of operating lease right of use assets and interest expenses on lease liabilities. Under U.S. GAAP we recognized a single lease cost, calculated so that the remaining cost of the lease is allocated over the remaining lease term on a straight-line basis.

2.Share-Based Compensation

Under IFRS, we recognized certain awards with graded vesting, for which only vesting condition is services as a separate share-based payment arrangement. However, under U.S. GAAP for this kind of awards with graded vesting schedules, the Company elects the straight-line recognition method for the entire award.

3.Government Grants

Under IFRS, we recognized a liability according to their fair value on the date of the grant’s receipt. The amount of the liability is reexamined each period, and any changes in the present value of the cash flows discounted at the original interest rate of the grant are recognized in profit or loss.

However, under U.S. GAAP, these grants are recognized at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement and included as a deduction from research and development.

4.Warrants exercisable into shares:

Under IFRS, we recognized certain warrants and pre-funded warrants as a liability due to the cashless exercise mechanism. Changes in the fair value of warrants which were classified as liability from commitment date to each reporting date were recorded as financial income (expense) in our statement of operations and comprehensive loss. Under U.S. GAAP, we recognized certain warrants and pre-funded warrants as part of the shareholders equity.

C. Research and development

For a description of our research and development programs and the amounts that we have incurred over the last three years pursuant to those programs, please see “ A. Operating Results — Research and Development Expenses.”

D. Trend Information

The trends impacting us are described elsewhere in our annual report on Form 20F, including in Items 4.B. and 5.B, and the financial statements included in this Form 6-K. As noted therein, since the change in our management at the end of 2024, we have shifted our efforts away from growth through acquisition to increasing profitability in our current operations. Efforts to increase profitability in our current operations is a challenging process. We are reviewing every product group and individual product to determine if it aligns with our longer-term objectives. This review is very complex, involving multiple criteria and many members of our management team, and depends on anticipating future trends and/or building products that meet future needs. However, our expectations may not be accurate or effective, and ultimately we may not achieve the results that we intend and our efforts to achieve profitability may not be successful.

Additionally, a particular element of this process may be the determination from time to time that the focus on our revised strategy will require us to close or divest certain product groups or specific products, including those product groups or specific products developed and manufactured by the companies which we have recently acquired. Such closures or divestments can result in material disruptions to our business, employees, customers, and partners, which may have a material adverse effect on our operations and financial condition, and which may also not achieve the results intended in the longer term.

E. Critical Accounting Estimates

We describe our material accounting policies and estimates in Note 2 to our annual consolidated financial statements contained elsewhere in this annual report. We believe that these accounting policies and estimates are critical in order to fully understand and evaluate our financial condition and results of operations.

We prepare our consolidated financial statements in accordance with U.S. GAAP.

In preparing these consolidated financial statements, management has made judgments, estimates and assumptions that affect the application of our accounting policies and the reported amounts recognized in the financial statements. On a periodic basis, we evaluate


our estimates, including those related to share-based compensation. We base our estimates on historical experience, authoritative pronouncements and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. For more information, please see Note 2 to our annual consolidated financial statements contained elsewhere in this annual report.

Other financial and operating data:

    

Year Ended

Year Ended

December 31,

    

December 31,

(In thousands of U.S. dollars)

2023

2024

EBITDA (loss)

(100,945)

(139,392)

Adjusted EBITDA (loss)

(105,317)

(63,593)

EBITDA is a non-GAAP measure and is defined as earnings before interest income, income tax, depreciation and amortization. We believe that EBITDA, as described above, should be useful in evaluating the performance of our business. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.

Adjusted EBITDA is a non-GAAP measure and is defined as earnings before other financial income, income tax, depreciation and amortization, share-based payments, impairment loss, Desktop Metal and Markforged transaction related expenses and other non-GAAP income, which consists of exceeded compensation for damaged inventory and fixed assets. Other financial expenses (income), net include exchange rate differences as well as finance expenses for revaluation of assets and liabilities. We believe that Adjusted EBITDA, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payment expenses, impairment loss and other non-GAAP income, and Adjusted EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to share-based payments.

EBITDA and Adjusted EBITDA can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as stock-based compensation, however, we may incur such expenses in the future which could impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison.

The following is a reconciliation of net loss to EBITDA and Adjusted EBITDA:

    

For the

    

For the

Year Ended

Year Ended

December 31,

December 31,

(In thousands of U.S. dollars)

2023

2024

Net loss

(57,075)

(99,858)

Tax expenses

62

397

Depreciation and amortization

1,972

2,642

Interest income

(45,904)

(42,573)

EBITDA (loss)

(100,945)

(139,392)

Finance (income) expenses from revaluation of assets and liabilities

(23,133)

52,344

Exchange rate differences

(1,722)

485

Share-based payments expenses

22,110

15,721

Desktop Metal and Markforged transaction related expenses

6,452

Other non-GAAP income

(1,627)

(486)

Impairment loss

1,283

Adjusted EBITDA (loss)

(105,317)

(63,593)